Device Cervical

Atlantis Anterior Cervical Plate System

Payments companies reported to CMS as associated with Atlantis Anterior Cervical Plate System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$3.5Massociated payments (2023-2025)
229clinicians with associated payments
1company reporting

By year

2023 $1.4M
2024 $1.5M
2025 $678K

Payments reported as associated with Atlantis Anterior Cervical Plate System, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Neurological Surgery $3.1M
Orthopaedic Surgery of The Spine $6,705
Orthopaedic Surgery $2,159
Physician Assistant $1,357
Surgical $575
Internal Medicine $168

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Atlantis Anterior Cervical Plate System

These are the largest totals companies reported as associated with Atlantis Anterior Cervical Plate System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Stephen Papadopoulos Phoenix, AZ Neurological Surgery $1,523,120.00
Regis Haid Atlanta, GA Neurological Surgery $1,514,786.00
Russell Buchanan Waterloo, IA Neurological Surgery $2,800.00
Michael Stoffman Niagara Falls, NY Neurological Surgery $1,050.00
Andrew Grossbach Columbus, OH Neurological Surgery $900.00
Justin Bundy Augusta, GA Orthopaedic Surgery of The Spine $875.00
Jeffrey Mullin Williamsville, NY Neurological Surgery $835.00
Praveen Mummaneni San Francisco, CA Neurological Surgery $800.00
Behnam Salari Hackettstown, NJ Orthopaedic Surgery of The Spine $768.94
Stephen Stephan La Jolla, CA Orthopaedic Surgery of The Spine $710.94

Prescribed Atlantis Anterior Cervical Plate System?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.